CDC Panel Overhaul: HHS Removes All Members
- In what he called a "clean sweep," health and Human services (HHS) Secretary Robert F.
- Kennedy stated in a Wall Street Journal commentary,later released as a press statement,that the ACIP would be reformed with new members.
- This announcement follows recent policy changes regarding COVID-19 vaccines, with the Food and Drug Management (FDA) planning to restrict future COVID-19 vaccines based on age and risk factors.
HHS Secretary Robert F. Kennedy Jr. decisively removed all members of the CDC’s Advisory Committee on Immunization Practices to rebuild public trust in vaccine science. This “clean sweep” of the primary_keyword committee, which guides federal vaccine policy, signals meaningful secondary_keyword reforms ahead. The ACIP’s overhaul reflects broader changes in vaccine strategy, especially regarding COVID-19, as the FDA considers new age and risk-factor guidelines. News Directory 3 reports on this pivotal shift in the approach to infectious diseases and public health. The reconstituted committee will address key issues. Discover what’s next as new members are selected and future vaccine recommendations are shaped.
HHS Reconstitutes CDC Vaccine Advisory Committee
Updated June 09,2025
In what he called a “clean sweep,” health and Human services (HHS) Secretary Robert F. Kennedy Jr. announced Monday the removal of all 17 members of the CDC’s Advisory Committee on Immunization practices (ACIP). This committee plays a key role in shaping federal vaccine recommendations.
Kennedy stated in a Wall Street Journal commentary,later released as a press statement,that the ACIP would be reformed with new members. The goal, he said, is to “reestablish public confidence in vaccine science” and improve the nation’s approach to infectious disease.
This announcement follows recent policy changes regarding COVID-19 vaccines, with the Food and Drug Management (FDA) planning to restrict future COVID-19 vaccines based on age and risk factors.
what’s next
The reconstituted ACIP is expected to address a range of infectious disease and vaccine-related issues, aiming to restore trust and optimize public health strategies.